EI
RXST icon

EAM Investors’s RxSight RXST Stock Holding History

EAM Investors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-95,607
Closed -$5.75M – 317
2024
Q2 		$5.75M Sell
95,607
-444
-0.5% -$25.4K 0.93% 6
2024
Q1 		$4.95M Sell
96,051
-11,259
-10% -$553K 0.77% 14
2023
Q4 		$4.33M Sell
107,310
-55,858
-34% -$1.64M 0.77% 19
2023
Q3 		$4.55M Sell
163,168
-58,247
-26% -$1.74M 0.88% 6
2023
Q2 		$6.38M Buy
221,415
+49,536
+29% +$1.1M 1.18% 2
2023
Q1 		$2.87M Buy
+171,879
New +$2.43M 0.56% 42
2022
Q3 		– Sell
-176,270
Closed -$2.48M – 325
2022
Q2 		$2.48M Buy
+176,270
New +$2.32M 0.61% 39

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Investors's RXST Position: Q3 2024 in Review

EAM Investors sold out of RxSight (RXST) in Q3 2024, closing a stake of 95,607 shares — an estimated $5.75M sold.

EAM Investors first reported a position in RXST in Q2 2022 and held it in 7 quarters. The position peaked at $6.38M in Q2 2023. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • EAM Investors reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • EAM Investors sold 95,607 RxSight shares in Q3 2024, an estimated $5.75M.
  • EAM Investors first reported a position in RxSight in Q2 2022 and held it in 7 quarters.
  • EAM Investors's RxSight position peaked at $6.38M in Q2 2023.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on EAM Investors's 13F filing for Q3 2024, filed 13 Nov 2024.